Key facts
- Notable investors include Shenzhen Yifeng Investment Management Enterprise.
- Status: Privately Held (backing).
- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Summed Medtech
- ·The full record, as it builds
Funding rounds
No funding rounds for Summed Medtech are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Summed Medtech
Developer of a drug delivery device system intended to revolutionize the drug injection process. The company offers patient-centric ergonomics, pen and auto injection formats, electronic options, customizable platform engineering, verification and quality management, human factors testing, regulatory and compliance support, and coordinated manufacturing and logistics, enabling pharmaceutical and biotechnology partners to maintain a traceable supply across markets.
- Sector
- Healthcare
- HQ
- Huzhou, China
- Founded
- 2023
- Website
- summed-medtech.com/
- Ownership
- Privately Held (backing)
Summed Medtech doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Summed Medtech shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Summed Medtech in its N-PORT filings yet. We sweep new filings monthly.